Oncology Drugs Market

  • Published on 2025-11-10
  • Report Code: 300
  • 187 pages
Oncology Drugs Market

COVID-19 Impact on Global Oncology Drugs Market By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer and Other Cancers); By Type (Chemotherapy, Targeted Therapy, Immunotherapy and Hormonal Therapy) and Region -Analysis of Market Size, Share and Trends for 2014 - 2019 and Forecasts to 2030

Table Of Content

Contents        

  1. Executive Summary
  2. Oncology Drugs Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  6. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  7. Recent Development, Policies & Regulatory Landscape
  8. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  9. Oncology Drugs Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  10. Oncology Drugs Market
    1. Market Size & forecast, 2019A-2030F
      1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  11. Oncology Drugs Market: Market Segmentation
    1.       By Regions
      1. North America:(U.S. and Canada)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  12. Oncology Drugs Market: Market Segmentation
    1. By disease indication: Market Share (2020-2030F)
      1. Lung Cancer, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Stomach Cancer, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Colorectal Cancer, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. Breast Cancer, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      5. Prostate Cancer, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      6. Liver Cancer, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      7. Esophagus Cancer, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      8. Cervical Cancer, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      9. Kidney Cancer, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      10. Bladder Cancer, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      11.  Other Cancers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    2. By type : Market Share (2020-2030F)
      1. Chemotherapy, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Targeted Therapy, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Immunotherapy, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. Hormonal Therapy, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  13. Company Profile
    1. Bayer AG
      1. Company Overview
      2. Company Total Revenue (Financials)
      3.  Market Potential
      4. Global Presence
      5.  Key Performance Indicators
      6. SWOT Analysis
      7. Product Launch
    2. Genentech, Inc.  
    3. Novartis AG
    4. Pfizer Inc.
    5. Bristol-Myers Squibb Company
    6. GlaxoSmithKline plc.
    7. Eli Lilly and Company
    8. AstraZeneca
    9. Sanofi
    10. Other prominent players
  14. Consultant Recommendation

**The above-given segmentation and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients